Radiation and Ethylene Oxide Terminal Sterilization Experiences with Drug Eluting Stent Products

被引:55
|
作者
Lambert, Byron J. [1 ]
Mendelson, Todd A. [1 ]
Craven, Michael D. [2 ]
机构
[1] Abbott Vasc, R&D, Temecula, CA 92589 USA
[2] Abbott Vasc, R&D, Santa Clara, CA USA
来源
AAPS PHARMSCITECH | 2011年 / 12卷 / 04期
关键词
combination devices; drug eluting stents; ethylene oxide sterilization; material compatibility; radiation sterilization; LESIONS RANDOMIZED-TRIALS; CORONARY-ARTERY LESIONS; CLINICAL-EVALUATION; SYSTEM EECSS; SPIRIT III; EVEROLIMUS; DEVICES;
D O I
10.1208/s12249-011-9644-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Radiation and ethylene oxide terminal sterilization are the two most frequently used processes in the medical device industry to render product within the final sterile barrier package free from viable microorganisms. They are efficacious, safe, and efficient approaches to the manufacture of sterile product. Terminal sterilization is routinely applied to a wide variety of commodity healthcare products (drapes, gowns, etc.) and implantable medical devices (bare metal stents, heart valves, vessel closure devices, etc.) along with products used during implantation procedures (catheters, guidewires, etc.). Terminal sterilization is also routinely used for processing combination products where devices, drugs, and/or biologics are combined on a single product. High patient safety, robust standards, routine process controls, and low-cost manufacturing are appealing aspects of terminal sterilization. As the field of combination products continues to expand and evolve, opportunity exists to expand the application of terminal sterilization to new combination products. Material compatibility challenges must be overcome to realize these opportunities. This article introduces the reader to terminal sterilization concepts, technologies, and the related standards that span different industries (pharmaceutical, medical device, biopharmaceuticals, etc.) and provides guidance on the application of these technologies. Guidance and examples of the application of terminal sterilization are discussed using experiences with drug eluting stents and bioresorbable vascular restoration devices. The examples provide insight into selecting the sterilization method, developing the process around it, and finally qualifying/validating the product in preparation for regulatory approval and commercialization. Future activities, including new sterilization technologies, are briefly discussed.
引用
收藏
页码:1116 / 1126
页数:11
相关论文
共 41 条
  • [31] Treatment of diffuse IN-stent restenosis with Drug-Eluting stents vs. intracoronary bEta-raDiation therapy: INDEED Study
    Park, Seong-Wook
    Lee, Seung-Whan
    Koo, Bon Kwon
    Park, Duk-Woo
    Lee, Se-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Hong, Myeong-Ki
    Kim, Jae-Joong
    Mori, Ken
    Lansky, Alexandra J.
    Mintz, Gary S.
    Lee, Myoung-Mook
    Park, Seung-Jung
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 131 (01) : 70 - 77
  • [32] SERUM LEVELS OF SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS ARE ASSOCIATED WITH RESTENOSIS AFTER DRUG-ELUTING STENT IMPLANTATION FOR STABLE ANGINA PECTORIS
    Byazrova, S.
    Kozlov, S.
    Gabbasov, Z.
    Kukharchuk, V.
    Masenko, V.
    ATHEROSCLEROSIS, 2015, 241 (01) : E214 - E214
  • [33] Soluble receptor for advanced glycation end products is associated with in-stent restenosis in patients with type 2 diabetes with drug-eluting coronary stents
    Park, Hun-Jun
    Seo, Suk Min
    Shin, Woo Seung
    Kim, Hee-Yeol
    Choi, Yoon Seok
    Koh, Yoon Seok
    Youn, Sung-Gyu
    Park, Mahn Won
    Chang, Kiyuk
    Kim, Pum Joon
    Jung, Hae-Ok
    Baek, Sang Hong
    Chung, Wook Sung
    Seung, Ki-Bae
    Yoo, Ki-Dong
    CORONARY ARTERY DISEASE, 2011, 22 (01) : 12 - 17
  • [34] SERUM LEVELS OF SOLUBLE RECEPTOR FOR ADVANCED END PRODUCTS ARE ASSOCIATED WITH RESTENOSIS OCCURRENCE IN PATIENTS WITH DIABETES MELLITUS AFTER DRUG-ELUTING STENT IMPLANTATION
    Kozlov, S.
    Gabbasov, Z.
    Byazrova, S.
    Saburova, O.
    Masenko, V.
    ATHEROSCLEROSIS, 2016, 252 : E139 - E139
  • [35] EFFECT OF GAMMA-RADIATION VERSUS ETHYLENE-OXIDE STERILIZATION OF DIALYZERS AND BLOOD LINES ON PLASMA-LEVELS OF GRANULOCYTE ELASTASE IN HEMODIALYZED PATIENTS
    HORL, WH
    RIEGEL, W
    SCHOLLMEYER, P
    CLINICAL NEPHROLOGY, 1985, 24 (05) : 232 - 236
  • [36] TIDES-ACS Trial: comparison of titanium-nitride-oxide coated bio-active-stent to the drug (everolimus)-eluting stent in acute coronary syndrome. Study design and objectives
    Colkesen, E. B.
    Eefting, F. D.
    Rensing, B. J.
    Suttorp, M. J.
    Ten Berg, J. M.
    Karjalainen, P. P.
    Van Der Heyden, J. A.
    MINERVA CARDIOANGIOLOGICA, 2015, 63 (01): : 21 - 29
  • [37] Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent
    Zeng, Wen-ping
    Zhang, Rui
    Li, Ran
    Luo, Jin-fang
    Hu, Xiao-feng
    PLOS ONE, 2017, 12 (01):
  • [38] Radiation Synthesis of pH-Sensitive Hydrogels From Carboxymethyl Cellulose/Poly(ethylene Oxide) Blends as Drug Delivery Systems
    El-Din, Horia M. Nizam
    El-Naggar, Abdel Wahab M.
    Abu-El Fadle, Faten I.
    INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, 2013, 62 (13) : 711 - 718
  • [39] Prognostic value of n-terminal ProB-Type natriuretic peptide and c-reactive protein in patients with ST-elevation myocardial infarction who underwent drug-eluting Stent implantation
    Sim, D. S.
    Jeong, M. H.
    Moon, J. Y.
    Kim, J. H.
    Hong, Y. J.
    Ahn, Y. X.
    Kang, J. C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8B): : 25C - 26C
  • [40] Clinical significance of the measurements of plasma N-terminal pro-B-type natriuretic peptide levels in patients with coronary artery disease who have undergone elective drug-eluting stent implantation
    Masaki, Yoshiyuki
    Shimada, Kazunori
    Kojima, Takahiko
    Miyauchi, Katsunni
    Inoue, Kenji
    Kiyanagi, Takashi
    Hiki, Makoto
    Fukao, Kosuke
    Hirose, Kuniaki
    Ohsaka, Hiromichi
    Kume, Atsumi
    Miyazaki, Tetsuro
    Ohmura, Hirotoshi
    Ohsaka, Akimichi
    Daida, Hiroyuki
    JOURNAL OF CARDIOLOGY, 2011, 57 (03) : 303 - 310